A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
EpilepsyDravet SyndromeDrug Resistant EpilepsyHealthy Controls
Interventions
OTHER

[18F]MPPF PET-MRI

"Patients will be seen during an first inclusion visit during which a review of eligibility criteria, medical history and a clinical examination will be done. Participants will be scheduled for a PET-MRI scan within 2 to 8 weeks. For all women of childbearing age a urine pregnancy test will be performed before the PET-MRI.~Anatomical MR imaging will be first acquired for anatomical co-registration and morphometry analyses (Neuromelanin sensitive images and 3D anatomical T1-weighted covering the whole brain volume with 1mm3 cubic voxels) After i.v. injection of a bolus of 180 MBq ± 10%, with a maximum of 198 MBq MBq, of \[18F\]-MPPF, a dynamic emission scan consisting of 35 frames of increasing duration (20s to 5min) will be acquired over 90-min post-injection"

Trial Locations (1)

69500

Hôpital Neurologique Pierre Wertheimer, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT07013331 - A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome | Biotech Hunter | Biotech Hunter